Novo Integrated Sciences, Inc. (NVOS)

Novo Integrated Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Year Ending	TTM	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Net Income	-24.33	-13.21	-32.85	-4.46	-4.92	-0.39
Depreciation & Amortization	2.92	3.1	3.87	2.37	1.99	0.31
Share-Based Compensation	1.82	0.87	1.76	1.03	2.92	0.07
Other Operating Activities	14.83	7.01	21.34	0.04	-0.43	-0.81
Operating Cash Flow	-4.75	-2.24	-5.88	-1.02	-0.44	-0.82
Capital Expenditures	-0.03	-0.05	-0.19	-0.26	-0.01	-0.11
Acquisitions	0	0	0.06	3.73	0	-0.51
Change in Investments	0	0	0.3	-0.47	0.67	-0.23
Investing Cash Flow	-0.03	-0.05	0.16	3	0.66	-0.84
Share Issuance / Repurchase	0.32	2.33	0	7.34	0.11	3.25
Debt Issued / Paid	5.26	-1.57	-0.44	-3.02	-0.39	-0.18
Other Financing Activities	0.01	0.01	0.02	-	-	-
Financing Cash Flow	5.59	0.76	-0.43	4.32	-0.27	3.07
Exchange Rate Effect	0.27	-0.23	0.03	-0.07	0.04	-0
Net Cash Flow	1.08	-1.76	-6.11	6.23	-0.02	1.41
Free Cash Flow	-4.78	-2.29	-6.07	-1.28	-0.45	-0.93
Free Cash Flow Margin	-35.39%	-18.24%	-51.75%	-13.76%	-5.77%	-9.87%
Free Cash Flow Per Share	-0.26	-0.23	-2.08	-0.52	-0.20	-0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).